Tailin Biotech: Important reminder on the implementation of “Tailin Bonds Transfer” redemption and the impending cessation of trading
Tailin Biotech: 9th indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Eighth indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Announcement on Obtaining Patent Certificates and Computer Software Copyright Registration Certificates
Tailin Biotech: Seventh indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: 6th indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Fifth indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Fourth indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Third indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Second indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: First indicative announcement on the implementation of “Tailin Bond-to-Bond” redemption
Tailin Biotech: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Directors
Tailin Biotech: Verification Opinions of Great Wall Securities Co., Ltd. on Zhejiang Tailin Biotechnology Co., Ltd.\'s early redemption of “Tailin Convertible Bonds”
Tailin Biotech: Legal Opinion of Attorney Guo Hao (Hangzhou) Firm on the Early Redemption of Convertible Corporate Bonds by Zhejiang Tailin Biotechnology Co., Ltd.
Tailin Biotech: Announcement on early redemption of “Tailin Convertible Bonds”
Tailin Biotech: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: An indicative announcement on “Tailin Bonds Transfer” expected to trigger redemption conditions
Tailin Biotech: Announcement on early termination of the holdings reduction plan and results for shareholders, some directors and senior management holding 5% or more of the company\'s shares